Akathisia induced by concurrent use of mirogabalin and sulfamethoxazole-trimethoprim: a case report

Abstract Background Mirogabalin and trimethoprim-sulfamethoxazole (TMP/SMX) are frequently used as supportive purpose during and/or after chemotherapy. Mirogabalin is used to treat neuropathic pain, whereas TMP/SMX is used to prevent pneumocystis pneumonia (PCP) in patients who are immunocompromised...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Takashi Nakashima, Kimitaka Suetsugu, Mina Nitta, Taichi Nagano, Makoto Yoshimitsu, Kenji Ishitsuka, Hideyuki Terazono
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2026-04-01
Saila:	Journal of Pharmaceutical Health Care and Sciences
Gaiak:	Mirogabalin Trimethoprim-sulfamethoxazole Akathisia Drug-drug interaction
Sarrera elektronikoa:	https://doi.org/10.1186/s40780-026-00578-y
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!